Home / Certolizumab Pegol / Belgium
BE ATC L04AB05 · updated 2 Nov 2026
Certolizumab Pegol shortage in Belgium
Is there a Certolizumab Pegol shortage in Belgium?
Yes. As of 2 Nov 2026, 3 Certolizumab Pegol products are reported short in Belgium, the first since 3 Dec 2024. The company estimate for the return is 31 Dec 2026. Main reason: other.
Also short in France. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Cimzia 200 mg (Orifarm) inj. sol. s.c. pre-filled syr. 2 x 1 ml | UCB Pharma | 3 Dec 2024 | 31 Dec 2026 | Other Other reason |
| BE | Cimzia 200 mg (Abacus Medicine) inj. sol. s.c. pre-filled pen 2 x 1 ml Autoclicks | UCB Pharma | 1 Jan 2025 | 31 Dec 2026 | Other Other reason |
| BE | Cimzia 200 mg (Abacus Medicine) inj. sol. s.c. pre-filled syr. 2 x 1 ml | UCB Pharma | 1 Jan 2025 | 31 Dec 2026 | Other Other reason |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.